Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Data Horizon Co.,Ltd. (3628.T)

Compare
386.00
-45.00
(-10.44%)
At close: April 4 at 3:30:00 PM GMT+9
Loading Chart for 3628.T
  • Previous Close 431.00
  • Open 431.00
  • Bid 386.00 x --
  • Ask 397.00 x --
  • Day's Range 380.00 - 431.00
  • 52 Week Range 353.00 - 819.00
  • Volume 29,100
  • Avg. Volume 60,427
  • Market Cap (intraday) 4.893B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) --
  • EPS (TTM) -75.69
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 29, 2022
  • 1y Target Est --

Data Horizon Co.,Ltd. provides medical information services in Japan. The company offers data health related services to insurers; and generic drug notification services, as well as analytics for data health planning, medical examinations, diabetic nephropathy and hypertension aggravation, and behavior and medical institution consultation services. It also provides health business support, receipt check, and health management support systems. The company was founded in 1981 and is headquartered in Hiroshima, Japan. Data Horizon Co.,Ltd. operates as a subsidiary of DeNA Co., Ltd.

www.dhorizon.co.jp

374

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 3628.T

View More

Performance Overview: 3628.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3628.T
17.17%
Nikkei 225 (^N225)
15.33%

1-Year Return

3628.T
51.75%
Nikkei 225 (^N225)
15.07%

3-Year Return

3628.T
79.60%
Nikkei 225 (^N225)
21.79%

5-Year Return

3628.T
42.77%
Nikkei 225 (^N225)
89.56%

Compare To: 3628.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3628.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    4.89B

  • Enterprise Value

    8.16B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.02

  • Price/Book (mrq)

    1.87

  • Enterprise Value/Revenue

    1.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.91%

  • Return on Assets (ttm)

    -7.59%

  • Return on Equity (ttm)

    -31.23%

  • Revenue (ttm)

    4.82B

  • Net Income Avi to Common (ttm)

    -959M

  • Diluted EPS (ttm)

    -75.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.14B

  • Total Debt/Equity (mrq)

    168.52%

  • Levered Free Cash Flow (ttm)

    -148.88M

Research Analysis: 3628.T

View More

Company Insights: 3628.T

Research Reports: 3628.T

View More

People Also Watch